496-65-1
496-65-1
Chemical Structure
(R)-Pantetheine
Synonym(s): Pantetheine
- CAS 番号: 496-65-1
- Formula:C11H22N2O4S
- Molecular Weight:278.37
IUPAC Name: (R)-2,4-dihydroxy-N-(3-((2-mercaptoethyl)amino)-3-oxopropyl)-3,3-dimethylbutanamide
InChIKey: ZNXZGRMVNNHPCA-VIFPVBQESA-N
SMILES: O=C([C@@H](C(C)(CO)C)O)NCCC(NCCS)=O
Biological Activity: (R)-Pantetheine is the biosynthetic precursor to CoA. (R)-Pantetheine and its corresponding disulfide pantethine, play a key role in metabolism as a building block of coenzyme A (CoA). (R)-Pantetheine has high toxicity[1][2][3].
| 製品番号 | 製品名 | 純度 | 製品説明 | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(R)-Pantetheine | 99.72% | (R)-Pantetheine is the biosynthetic precursor to CoA. (R)-Pantetheine and its corresponding disulfide pantethine, play a key role in metabolism as a building block of coenzyme A (CoA). (R)-Pantetheine has high toxicity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(R)-Pantetheine (Standard) | 97.18% | (R)-Pantetheine (Standard) is the analytical standard of (R)-Pantetheine. This product is intended for research and analytical applications. (R)-Pantetheine is the biosynthetic precursor to CoA. (R)-Pantetheine and its corresponding disulfide pantethine, play a key role in metabolism as a building block of coenzyme A (CoA). (R)-Pantetheine has high toxicity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(R)-Pantetheine-d4 | (R)-Pantetheine-d4 (Pantetheine-d4) is the deuterium labeled (R)-Pantetheine (HY-126050). (R)-Pantetheine is the biosynthetic precursor to CoA. (R)-Pantetheine and its corresponding disulfide pantethine, play a key role in metabolism as a building block of coenzyme A (CoA). (R)-Pantetheine has high toxicity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Rothmann M, et al. Metabolic perturbation of an essential pathway: evaluation of a glycine precursor of coenzyme A. J Am Chem Soc. 2013 Apr 24;135(16):5962-5. [Content Brief]
- [2]. Wang Y, et al. Ligand supplementation restores the cancer therapy efficacy of an antirheumatic drug auranofin from serum inactivation. bioRxiv, 2024: 2024.01. 25.577173.
- [3]. Moretto L, et al. Dissecting how modular polyketide synthase ketoreductases interact with acyl carrier protein-attached substrates. Chem Commun (Camb). 2017 Oct 25;53(83):11457-11460. [Content Brief]
